Tren

Tren

tranexamic acid

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries
Concise Prescribing Info
Contents
Tranexamic acid
Indications/Uses
Haemorrhage or threatened haemorrhage associated w/ excessive fibrinolysis. Management of haemophiliacs undergoing dental extractions, prophylaxis of hereditary angioedema.
Dosage/Direction for Use
Adult Cap 4-6 cap daily in 2-3 divided doses. Inj 0.5-1 g tds by slow IV inj.
Administration
May be taken with or without food.
Contraindications
History or risk of thrombosis, acquired disturbances of colour vision.
Special Precautions
Haematuria caused by renal parenchymal disease, thrombotic states. Renal impairment. Lactation.
Adverse Reactions
Anorexia, hypnosia, pruritus, erythema, rash, GI disturbances, disturbances in colour vision (discontinue).
Drug Interactions
OCs, oestrogens, factor IX complex.
MIMS Class
ATC Classification
B02AA02 - tranexamic acid ; Belongs to the class of amino acid antifibrinolytics. Used in the treatment of hemorrhage.
Presentation/Packing
Form
Tren cap 250 mg
Packing/Price
50 × 10's
Form
Tren inj 100 mg/mL
Packing/Price
5 mL x 50 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in